Modulating the lung–gut axis: A randomized controlled trial of Xie Bai Zeng Ye decoction on intestinal flora and mucosal immunity in children with post-infectious cough
This exploratory study suggests that XBZY may be a promising treatment option for children with post-infectious cough characterized by lung heat and Yin deficiency. Compared with Montelukast Sodium, XBZY demonstrated superior short-term improvements in cough resolution, symptom relief, quality of life, intestinal barrier function, and gut microbiota modulation, while maintaining good safety. These findings highlight the potential role of the lung-gut axis in pediatric respiratory care and support the integration of TCM-based strategies; however, larger, blinded, and longer-term studies are needed to validate these results and assess their broader clinical applicability.
Authors
- Guoping Zhan (ORCID: https://orcid.org/0000-0002-8399-0876)
- Jing Luo
- Dan Zhang (ORCID: https://orcid.org/0000-0003-1560-3624)
- Yi Ding (ORCID: https://orcid.org/0009-0002-7547-9493)
Institutions
- Changsha University (CN)
- Guangzhou Development Zone Hospital (CN)
- Shenzhen Pingle Orthopedic Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1097/md.0000000000045819
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00